Importantly, we find a positive mutual regulation between Cx26 and PI3K/Akt pathway, which confers acquired gefitinib resistance in NSCLC cells by GJIC-independent induction of EMT. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.